Observatory of Immunological Thrombopenic Purpura in the Brest Region

Launched by UNIVERSITY HOSPITAL, BREST · Aug 13, 2024

Keywords

ClinConnect Summary

The "Observatory of Immunological Thrombopenic Purpura in the Brest Region" is a clinical trial that aims to gather important information about patients who have a condition called Immune Thrombocytopenia (ITP). ITP is a disorder that leads to a low level of platelets in the blood, which can cause easy bruising and bleeding. This study is taking place at the Brest University Hospital and is currently looking for participants to join.

To be eligible for this trial, patients must have a diagnosis of ITP and be willing to take part in the study. However, individuals with other types of low platelet counts or those who are under guardianship cannot participate. The study will involve tracking patients' conditions over time, which means participants can expect regular check-ins and monitoring. This information will help doctors better understand ITP and improve treatment options in the future. If you or a loved one has ITP and are interested in learning more, this could be a valuable opportunity to contribute to important research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with ITP agree to participate
• Exclusion Criteria:
• • Other thrombocythopenia other than ITP
• • Patients Under guardianship
• • Patients without national social security